Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Ghosh (Kharagpur, India), S. Rathnakaram (Kharagpur, India), S. Kaushik (New Delhi, India), R. Arya (New Delhi, India), R. Nanda (New Delhi, India), P. Bhattacharyya (Newtown, Kolkata, India), S. Roy Chowdhury (Kolkata, India), R. Banerjee (Kharagpur, India), K. Chaudhury (Kharagpur, India). GC MS based untargeted metabolomics for understanding the pathophysiology of asthma COPD overlap (ACO). 5471

Member's Comments

No comment yet.

Related content which might interest you: 2D cross-omics integrated enrichment analysis reveals insights into COPD pathogenesis Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017 Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Identification of aspirin-induced asthma (AIA) subphenotypes using a clustering approach Source: Annual Congress 2012 - Different ways to phenotype asthma Year: 2012 NMR serum metabolomics for understanding the pathophysiology of COPD associated PH: A pilot study Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology Year: 2005 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Integrating fingerprints: molecular phenotyping of severe asthma Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Gene signalling heterogeneity in exacerbations of COPD determined by microarray analysis of PBMC mRNA Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis Source: Eur Respir J 2014; 44: 860-872 Year: 2014 A network-based approach to defining phenotypes in COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 FKBP5 a candidate for corticosteroid insensitivity in COPD Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes Source: ERS Lung Science Conference 2016 Year: 2016 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018